Annual CAPEX
$892.00 K
-$407.10 K-31.34%
31 December 2023
Summary:
AC Immune SA annual capital expenditures is currently $892.00 thousand, with the most recent change of -$407.10 thousand (-31.34%) on 31 December 2023. During the last 3 years, it has fallen by -$927.70 thousand (-50.98%). ACIU annual CAPEX is now -69.06% below its all-time high of $2.88 million, reached on 31 December 2021.ACIU CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CAPEX
$211.50 K
+$145.90 K+222.41%
01 September 2024
Summary:
AC Immune SA quarterly capital expenditures is currently $211.50 thousand, with the most recent change of +$145.90 thousand (+222.41%) on 01 September 2024. Over the past year, it has dropped by -$112.60 thousand (-34.74%). ACIU quarterly CAPEX is now -81.36% below its all-time high of $1.13 million, reached on 31 March 2018.ACIU Quarterly CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CAPEX
$735.00 K
-$112.60 K-13.28%
01 September 2024
Summary:
AC Immune SA TTM capital expenditures is currently $735.00 thousand, with the most recent change of -$112.60 thousand (-13.28%) on 01 September 2024. Over the past year, it has dropped by -$42.80 thousand (-5.50%). ACIU TTM CAPEX is now -75.45% below its all-time high of $2.99 million, reached on 30 September 2021.ACIU TTM CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ACIU CAPEX Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | -31.3% | -34.7% | -5.5% |
3 y3 years | -51.0% | -59.9% | -75.5% |
5 y5 years | -53.0% | -55.8% | -53.3% |
ACIU CAPEX High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3 years | -69.1% | at low | -73.5% | +260.3% | -75.5% | +27.1% |
5 y | 5 years | -69.1% | at low | -76.8% | +260.3% | -75.5% | +27.1% |
alltime | all time | -69.1% | +536.7% | -81.4% | +695.8% | -75.5% | +763.7% |
AC Immune SA CAPEX History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sept 2024 | - | $211.50 K(+222.4%) | $735.00 K(-13.3%) |
June 2024 | - | $65.60 K(-77.0%) | $847.60 K(-11.8%) |
Mar 2024 | - | $284.90 K(+64.7%) | $961.00 K(+7.7%) |
Dec 2023 | $892.00 K(-31.3%) | $173.00 K(-46.6%) | $892.10 K(+14.7%) |
Sept 2023 | - | $324.10 K(+81.1%) | $777.80 K(+34.5%) |
June 2023 | - | $179.00 K(-17.1%) | $578.10 K(-37.9%) |
Mar 2023 | - | $216.00 K(+268.0%) | $930.50 K(-28.4%) |
Dec 2022 | $1.30 M(-54.9%) | $58.70 K(-52.8%) | $1.30 M(-36.3%) |
Sept 2022 | - | $124.40 K(-76.6%) | $2.04 M(-16.5%) |
June 2022 | - | $531.40 K(-9.1%) | $2.44 M(-5.9%) |
Mar 2022 | - | $584.60 K(-26.9%) | $2.59 M(-10.0%) |
Dec 2021 | $2.88 M(+58.4%) | $799.20 K(+51.7%) | $2.88 M(-3.7%) |
Sept 2021 | - | $526.80 K(-22.9%) | $2.99 M(+8.2%) |
June 2021 | - | $683.60 K(-21.7%) | $2.77 M(+11.9%) |
Mar 2021 | - | $873.40 K(-4.0%) | $2.47 M(+36.0%) |
Dec 2020 | $1.82 M(-4.1%) | $909.50 K(+202.1%) | $1.82 M(+22.9%) |
Sept 2020 | - | $301.10 K(-22.8%) | $1.48 M(-10.7%) |
June 2020 | - | $390.00 K(+78.0%) | $1.66 M(+3.4%) |
Mar 2020 | - | $219.10 K(-61.6%) | $1.60 M(-15.5%) |
Dec 2019 | $1.90 M | $570.80 K(+19.2%) | $1.90 M(+20.5%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sept 2019 | - | $478.90 K(+43.0%) | $1.57 M(+27.1%) |
June 2019 | - | $334.80 K(-34.7%) | $1.24 M(-3.1%) |
Mar 2019 | - | $512.90 K(+107.0%) | $1.28 M(-32.7%) |
Dec 2018 | $1.90 M(+3.8%) | $247.80 K(+73.3%) | $1.90 M(+17.5%) |
Sept 2018 | - | $143.00 K(-61.8%) | $1.62 M(-9.8%) |
June 2018 | - | $374.00 K(-67.0%) | $1.79 M(-24.3%) |
Mar 2018 | - | $1.13 M(-3295.8%) | $2.37 M(+29.3%) |
Dec 2017 | $1.83 M(+100.5%) | -$35.50 K(-111.2%) | $1.83 M(-14.9%) |
Sept 2017 | - | $317.90 K(-66.5%) | $2.15 M(+0.3%) |
June 2017 | - | $948.50 K(+58.5%) | $2.14 M(+64.9%) |
Mar 2017 | - | $598.40 K(+110.5%) | $1.30 M(+42.4%) |
Dec 2016 | $912.60 K(+259.9%) | $284.30 K(-8.9%) | $912.60 K(+43.9%) |
Sept 2016 | - | $312.10 K(+197.8%) | $634.20 K(+42.3%) |
June 2016 | - | $104.80 K(-50.4%) | $445.60 K(+17.3%) |
Mar 2016 | - | $211.40 K(+3483.1%) | $379.90 K(+49.8%) |
Dec 2015 | $253.60 K(+81.0%) | $5900.00(-95.2%) | $253.60 K(+2.4%) |
Sept 2015 | - | $123.50 K(+215.9%) | $247.70 K(+99.4%) |
June 2015 | - | $39.10 K(-54.1%) | $124.20 K(+45.9%) |
Mar 2015 | - | $85.10 K | $85.10 K |
Dec 2014 | $140.10 K | - | - |
FAQ
- What is AC Immune SA annual capital expenditures?
- What is the all time high annual CAPEX for AC Immune SA?
- What is AC Immune SA annual CAPEX year-on-year change?
- What is AC Immune SA quarterly capital expenditures?
- What is the all time high quarterly CAPEX for AC Immune SA?
- What is AC Immune SA quarterly CAPEX year-on-year change?
- What is AC Immune SA TTM capital expenditures?
- What is the all time high TTM CAPEX for AC Immune SA?
- What is AC Immune SA TTM CAPEX year-on-year change?
What is AC Immune SA annual capital expenditures?
The current annual CAPEX of ACIU is $892.00 K
What is the all time high annual CAPEX for AC Immune SA?
AC Immune SA all-time high annual capital expenditures is $2.88 M
What is AC Immune SA annual CAPEX year-on-year change?
Over the past year, ACIU annual capital expenditures has changed by -$407.10 K (-31.34%)
What is AC Immune SA quarterly capital expenditures?
The current quarterly CAPEX of ACIU is $211.50 K
What is the all time high quarterly CAPEX for AC Immune SA?
AC Immune SA all-time high quarterly capital expenditures is $1.13 M
What is AC Immune SA quarterly CAPEX year-on-year change?
Over the past year, ACIU quarterly capital expenditures has changed by -$112.60 K (-34.74%)
What is AC Immune SA TTM capital expenditures?
The current TTM CAPEX of ACIU is $735.00 K
What is the all time high TTM CAPEX for AC Immune SA?
AC Immune SA all-time high TTM capital expenditures is $2.99 M
What is AC Immune SA TTM CAPEX year-on-year change?
Over the past year, ACIU TTM capital expenditures has changed by -$42.80 K (-5.50%)